General Information of Drug Inactive Ingredient (DIG) (ID: E00144)

DIG Name
Monothioglycerol
Synonyms
3-Mercapto-1,2-propanediol; Monothioglycerol; 1-Thioglycerol; 96-27-5; 3-Mercaptopropane-1,2-diol; THIOGLYCEROL; alpha-Thioglycerol; Thioglycerine; Thioglycerin; Thiovanol; 2,3-Dihydroxypropanethiol; Glycerol-1-thiol; 1-Mercaptoglycerol; 1-Monothioglycerol; Monothioglycerin; 3-Sulfanylpropane-1,2-diol; alpha-Thiolglycerol; 1-Mercapto-2,3-propanediol; alpha-Monothioglycerol; Glycerol, 1-thio-; 1-Thio-2,3-propanediol; 1,2-Propanediol, 3-mercapto-; USAF CB-37; USAF B-40; 3-Mercapto-1,2-propanediole; NSC 5370; .alpha.-Thioglycerol; .alpha.-Thiolglycerol; Monothioglycerol [NF]; .alpha.-Monothioglycerol; MFCD00004879; CHEBI:74537; Monothioglycerol (NF); NCGC00165973-01; DSSTox_CID_26512; DSSTox_RID_81681; DSSTox_GSID_46512; 3-Mercapto-1,2-propanediol, 90 wt% aqueous solution; CAS-96-27-5; 3-Mercapto-propane-1,2-diol; HSDB 2184; EINECS 202-495-0; BRN 1732046; AI3-25462; 1, 3-mercapto-; ACMC-209ukn; 3-Thiopropane-1,2-diol; WLN: SH1YQ1Q; SCHEMBL4462; 1-Thioglycerol, >=97%; 3-01-00-02339 (Beilstein Handbook Reference); 2,3-dihydroxy-1-propanethiol; 3-Sulfanyl-1,2-propanediol #; CHEMBL1398948; DTXSID5046512; NSC5370; 1-Thioglycerol, BioXtra, >=97%; NSC-5370; Tox21_112276; Tox21_202881; ANW-43893; 1-Thioglycerol, >=99.0% (GC); 3-$l^{1}-sulfanylpropane-1,2-diol; AKOS015856773; Tox21_112276_1; NE10365; NCGC00165973-02; NCGC00260427-01; LS-12963; 1-Thioglycerol, dist., >=98.0% (GC); FT-0615943; S0374; V0535; D05075; 124795-EP2295426A1; 124795-EP2295427A1; Q2745755; Z1939437499; 1-Thioglycerol, liquid, BioReagent, suitable for cell culture, >=97% (titration); 1-Thioglycerol, PharmaGrade, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
DIG Function
Antimicrobial preservative; Antioxidant
Formula
C3H8O2S
Canonical SMILES
C(C(CS)O)O
InChI
1S/C3H8O2S/c4-1-3(5)2-6/h3-6H,1-2H2
InChIKey
PJUIMOJAAPLTRJ-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 108.16 Topological Polar Surface Area 41.5
XlogP -0.8 Complexity 32
Heavy Atom Count 6 Rotatable Bond Count 2
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

1 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Bendamustine hydrochloride DMFH15Z leukaemia [2A60-2B33] Bendamustine Hydrochloride 100mg/4ml solution F24290
------------------